Lupin trades with traction on the BSE

09 Mar 2015 Evaluate

Lupin is currently trading at Rs. 1865.55, up by 27.25 points or 1.48% from its previous closing of Rs. 1838.30 on the BSE.

The scrip opened at Rs. 1840.00 and has touched a high and low of Rs. 1874.00 and Rs. 1834.60 respectively. So far 20484 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1874.00 on 09-Mar-2015 and a 52 week low of Rs. 903.95 on 27-May-2014.

Last one week high and low of the scrip stood at Rs. 1874.00 and Rs. 1704.60 respectively. The current market cap of the company is Rs. 83526.99 crore.

The promoters holding in the company stood at 46.66% while Institutions and Non-Institutions held 42.51% and 10.83% respectively.

Pharma major, Lupin has entered into a partnership with Acceliant, a global technology provider of advanced clinical trial data management solutions. Under this partnership, Lupin would leverage Acceliant's clinical trial platform for its clinical research and trials across Lupin Research programs.

Acceliant platforms ensure smooth execution of clinical data management activities such as database design, UAT and various report formats for business intelligence. It gives a client partner like Lupin a collaborative environment that brings global research teams to work within a single shared environment.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×